Journal Information
Most often read
11129
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysisAshish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, ... Preeti Malik
Ann Hepatol. 2021;21C:273
11129
Open access
Open Article
9667
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liverFernando Bessone, Nelia Hernandez, Martin Tagle, Marco Arrese, Raymundo Parana, Nahum Méndez-Sánchez, Ezequiel Ridruejo, Manuel Mendizabal, ... Marcelo Silva
Ann Hepatol. 2021;24C:100321
9667
Open access
9288
An Integrated Review of the Hepatorenal SyndromeAlicia S. Ojeda-Yuren, Eira Cerda-Reyes, Maria R. Herrero-Maceda, Graciela Castro-Narro, Salvatore Piano
Ann Hepatol. 2021;22C:236
9288
Open access
8665
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature reviewAshley Bloom, Stephen Bloom, Hannah Silva, Amanda J. Nicoll, Rohit Sawhney
Ann Hepatol. 2021;25C:100549
8665
Open access
8493
Silymarin is an ally against insulin resistance: A reviewKarla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:255
8493
Open access
8023
Progression of intraductal papillary neoplasm of the bile duct (IPNB): A proposed model through the observation of patients with non-resected tumorsVor Luvira
Ann Hepatol. 2021;23C:100299
8023
Open access
7988
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formationQifan Lu, Zhaoyan Jiang, Qihan Wang, Hai Hu, Gang Zhao
Ann Hepatol. 2021;23C:100289
7988
Open access
7409
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleMohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio
Ann Hepatol. 2021;22C:249
7409
Open access
6880
Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysisIsadora Z. Bombassaro, Cristiane V. Tovo, Ângelo Z. de Mattos, Marcelo Ahlert, Talita Chiesa, Angelo A. de Mattos
Ann Hepatol. 2021;26C:100541
6880
Open access
4790
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosisMateo Porres-Aguilar, Alejandro Lazo-Langner, Arturo Panduro, Misael Uribe
Ann Hepatol. 2021;23C:100356
4790
Open access
4571
STAT3: A key regulator in liver fibrosisJie Zhao, Yong-Fen Qi, Yan-Rong Yu
Ann Hepatol. 2021;21C:224
4571
Open access
4462
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the diseaseGuillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri
Ann Hepatol. 2021;21C:212
4462
Open access
4173
Laparoscopic repair of transected right hepatic artery during cholecystectomy: A report of two casesWu Bao-Qiang, Hu Jun, Liu Wen-Song, Jiang Yong, Chen Xue-Min, Sun Dong-Lin
Ann Hepatol. 2021;21C:161
4173
Open access
4075
Liquid biopsy in chronic liver diseaseHugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera
Ann Hepatol. 2021;20C:197
4075
Open access
3996
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 casesFaxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
Ann Hepatol. 2021;21C:267
3996
Open access
Open Article
3950
Prognostic value of liver biochemical parameters for COVID-19 mortalityLin Ye, Bin Chen, Yitong Wang, Yi Yang, Jiling Zeng, Guangtong Deng, Yuhao Deng, Furong Zeng
Ann Hepatol. 2021;21C:279
3950
Open access
Open Article
3854
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studiesUmar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris
Ann Hepatol. 2021;20C:254
3854
Open access
3573
Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomyJie Li, Guang-Sheng Yang, Ke-Jian Sun, Yan Ma, Xiao-Wang Bi, Xu Han
Ann Hepatol. 2021;20C:245
3573
Open access
3534
Visualising and quantifying intestinal permeability -where do we standMonica Rusticeanu, Vincent Zimmer, Frank Lammert
Ann Hepatol. 2021;23C:266
3534
Open access
3457
FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseasesKalliopi Zachou, Vasiliki Lygoura, Pinelopi Arvaniti, Georgios Giannoulis, Nikolaos K. Gatselis, George K. Koukoulis, George N. Dalekos
Ann Hepatol. 2021;22C:285
3457
Open access